Wishing you all the joys of the season! 
Middle East & Africa Heart Transplant Market Forecast to 2030
Middle East & Africa Heart Transplant Market Forecast to 2030 – Regional Analysis – by Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), and End User (Hospitals, Cardiac Centers, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Target Disease Incidence Bolsters Middle East & Africa Heart Transplant Market
The World Health Organization (WHO) states cardiovascular disease (CVD) is one of the leading causes of death worldwide. A few of the major contributors to the rising prevalence of CVDs are ethnicity, family history, and age. Other notable factors include increasing tobacco consumption, high cholesterol, hypertension; and diseases such as obesity, dyslipidemia, and diabetes. According to the WHO, deaths due to CVDs across the world will rise from ~17 million in 2016 to 23.6 million by 2030. Moreover, the global cost burden of CVDs would reach US$ 1,044 billion by 2030 from US$ 863 billion in 2010. Since its opening in 2017, the multi-organ transplant centre Cleveland Clinic Abu Dhabi in the United Arab Emirates has completed 386 transplants. Additionally, as of 2023, more than 431 heart transplant procedures have been performed at the KFSHRC Saudi Arabia overall since the program’s inception in 1989. Therefore, the rising incidence of CVDs and heart failure drives the growth of the heart transplant market.
Middle East & Africa Heart Transplant Market Overview
The Middle East & Africa heart transplant market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The increase in prevalence of heart failure in geriatric population of the region and improving healthcare facilities is fueling the growth of heart transplant market in Middle East & Africa. Saudi Arabia is estimated to register considerable growth in the heart transplant market. The country has a large obese and geriatric population prone to cardiovascular disorders. According to the WHO, coronary heart disease deaths in Saudi Arabia reached 39,037 in 2020, accounting for 29.13% of total deaths. A report published in the Journal of Nature and Science of Medicine states the estimated number of heart failure in the country was 455,222 in 2021, with 37,935 new cases arising every year. Coronary heart disease is characterized by the build-up of fatty substances in the arteries leading to heart block or blood flow interruption to the heart; treating this condition needs heart transplant intervention. Olive oil consumption also poses a risk of cardiovascular-related deaths and all-cause deaths.
Public organizations and the government have initiated programs to enhance healthcare services in the country. In the last few years, the private sector has been playing an important role in the healthcare system in Saudi Arabia, owing to the rising investments. The government of Saudi Arabia has launched the Saudi Vision 2030 program to reduce oil dependence and diversify the economy. This has led to significant developments in healthcare services and the high adoption rate of advanced technologies. In January 2023, Saudi doctors performed a heart transplant on an eight-month-old girl, claiming she was the youngest patient in the Middle East to have undergone the procedure. Hence, the rising prevalence of cardiovascular disorders and heart failure in the country, developments in healthcare services, and increasing investments by government and private organizations are expected to boost the growth of the heart transplant market in Saudi Arabia in the future.
Middle East & Africa Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Heart Transplant Market Segmentation
The Middle East & Africa heart transplant market is segmented into surgery type, type, end user, and country.
Based on surgery type, the Middle East & Africa heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the Middle East & Africa heart transplant market in 2022.
In terms of type, the Middle East & Africa heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the Middle East & Africa heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.
Based on end user, the Middle East & Africa heart transplant market is segmented into hospitals, cardiac centres, and others. The hospitals segment held the largest share of the Middle East & Africa heart transplant market in 2022.
Based on country, the Middle East & Africa heart transplant market is segmented into Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa heart transplant market in 2022.
Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, and LivaNova Plc are some of the leading companies operating in the Middle East & Africa heart transplant market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Middle East & Africa heart transplant market was valued at US$ 213.52 million in 2022 and is expected to reach US$ 432.74 million by 2030, registering a CAGR of 9.2% from 2022 to 2030. Use of AI in transplantation procedures and growing geriatric population are among the critical factors attributed to the Middle East & Africa heart transplant market expansion.
A uniquely designed system backed by artificial intelligence (AI) facilitates the detection of early signs and seriousness of the host rejection post-heart transplantation. The endomyocardial biopsy (EMB) screening signifies the standard of care for identifying allograft rejections after a heart transplant. In 2022, a new AI system was designed known as the Cardiac Rejection Assessment Neural Estimator (CRANE), which can be used in tandem with medical assessments for rapid and precise diagnosis. CRANE also helps reduce differences regarding the presence and severity of heart rejection in the host body. It is a deeplearning-based AI system for the automated assessment of gigapixel whole-slide images obtained from EMBs. In 2020, the National Institute of Health granted US$ 3.2 million to studies based on the exploration of the capabilities of AI in heart transplants. With this grant, researchers from Perelman School of Medicine (the University of Pennsylvania), Case Western Reserve University, Cleveland Clinic, and Cedars-Sinai Medical Center aimed to study what causes the rejection of a new heart and how to manage it. They used AI to analyze cardiac biopsy tissue images, finding the types of immune cells that play an instrumental role in new heart rejection. Thus, the adoption of AI in heart transplantation procedures is likely to bring new trends in the market in the coming years.
On the contrary, high cost of surgeries hampers the Middle East & Africa heart transplant market.
Based on surgery type, the Middle East & Africa heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart segment held 79.0% share of Middle East & Africa heart transplant market in 2022, amassing US$ 168.69 million. It is projected to garner US$ 347.24 million by 2030 to expand at 9.4% CAGR during 2022-2030.
In terms of type, the Middle East & Africa heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held 74.1% share of Middle East & Africa heart transplant market in 2022, amassing US$ 158.29 million. It is projected to garner US$ 315.44 million by 2030 to expand at 9.0% CAGR during 2022-2030. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.
Based on end user, the Middle East & Africa heart transplant market is segmented into hospitals, cardiac centers, and others. The hospitals segment held 59.2% share of Middle East & Africa heart transplant market in 2022, amassing US$ 126.44 million. It is projected to garner US$ 262.18 million by 2030 to expand at 9.5% CAGR during 2022-2030.
By country, the Middle East & Africa heart transplant market has been categorized into Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 39.9% share of Middle East & Africa heart transplant market in 2022. It was assessed at US$ 85.15 million in 2022 and is likely to hit US$ 178.12 million by 2030, exhibiting a CAGR of 9.7% during 2022-2030.
Key players operating in the Middle East & Africa heart transplant market are Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, and LivaNova Plc, among others.
In June 2021, Abbott Laboratories announced that it has enhanced its capacity and supply for mechanical circulatory support (MCS) devices, Medtronic HeartWare ventricular assist device (HVAD). In addition, the company announced providing support training and education programs for its HeartMate 3 heart pump.
In January 2020, Abbott Laboratories announced that the Food and Drug Administration (FDA) approved its HeartMate 3 left ventricular assist device (LVAD). LVAD is a minimally invasive surgical technique for the placement that avoids open surgery. In 2017, the FDA approved HeartMate 3 for bridge therapy for patients awaiting a heart transplant.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa heart transplant market , thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Heart Transplant Market – Key Industry Dynamics
4.1 Heart Transplant Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Target Disease Incidence
4.3 Market Restraints
4.3.1 High Cost of Surgeries
4.4 Market Opportunities
4.4.1 Improving Healthcare Capabilities and Growing Patient Pool in Emerging Nations
4.5 Future Trends
4.5.1 Use of AI in Transplantation Procedures
4.6 Impact of Drivers and Restraints:
5. Heart Transplant Market – Middle East & Africa Market Analysis
5.1 Heart Transplant Market Revenue (US$ Million), 2020 – 2030
5.2 Heart Transplant Market Forecast and Analysis
6. Middle East & Africa Heart Transplant Market Analysis – Surgery Type
6.1 Overview
6.2 Orthotopic Heart Transplant
6.2.1 Overview
6.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Heterotopic Heart Transplant
6.3.1 Overview
6.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Heart Transplant Market Analysis – Type
7.1 Overview
7.2 Donor Live Heart
7.2.1 Overview
7.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Artificial Hearts
7.3.1 Overview
7.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Ventricular Assisted Device
7.3.2.1.1 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Total Artificial Heart
7.3.2.2.1 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Heart Transplant Market Analysis – End User
8.1 Overview
8.2 Hospitals
8.2.1 Overview
8.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Cardiac Centers
8.3.1 Overview
8.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Heart Transplant Market – Country Analysis
9.1 Middle East and Africa
9.1.1 Middle East and Africa Heart Transplant Market Overview
9.1.2 Middle East and Africa Heart Transplant Market Revenue and Forecasts and Analysis – By Country
9.1.2.1 Saudi Arabia: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.1.1 Overview
9.1.2.1.2 Saudi Arabia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.2.1.3 Saudi Arabia Heart Transplant Market Breakdown by Surgery Type
9.1.2.1.4 Saudi Arabia Heart Transplant Market Breakdown by Type
9.1.2.1.4.1 Saudi Arabia Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.1.5 Saudi Arabia Heart Transplant Market Breakdown by End User
9.1.2.2 South Africa: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.1 Overview
9.1.2.2.2 South Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.2.2.3 South Africa Heart Transplant Market Breakdown by Surgery Type
9.1.2.2.4 South Africa Heart Transplant Market Breakdown by Type
9.1.2.2.4.1 South Africa Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.2.5 South Africa Heart Transplant Market Breakdown by End User
9.1.2.3 UAE: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.3.1 Overview
9.1.2.3.2 United Arab Emirates Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.2.3.3 United Arab Emirates Heart Transplant Market Breakdown by Surgery Type
9.1.2.3.4 United Arab Emirates Heart Transplant Market Breakdown by Type
9.1.2.3.4.1 United Arab Emirates Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.3.5 United Arab Emirates Heart Transplant Market Breakdown by End User
9.1.2.4 Rest of Middle East & Africa: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.4.1 Overview
9.1.2.4.2 Rest of Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.2.4.3 Rest of Middle East and Africa Heart Transplant Market Breakdown by Surgery Type
9.1.2.4.4 Rest of Middle East and Africa Heart Transplant Market Breakdown by Type
9.1.2.4.4.1 Rest of Middle East and Africa Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.4.5 Rest of Middle East and Africa Heart Transplant Market Breakdown by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Heart Transplant Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Terumo Corp
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Abbott Laboratories
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 SynCardia Systems LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 LivaNova Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About the Research Team
LIST OF TABLES
Table 2. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Table 3. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) – Surgery Type
Table 4. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) – Type
Table 5. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) – End User
Table 6. Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Country
Table 7. Saudi Arabia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Surgery Type
Table 8. Saudi Arabia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Type
Table 9. Saudi Arabia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Artificial Hearts
Table 10. Saudi Arabia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 11. South Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Surgery Type
Table 12. South Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Type
Table 13. South Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Artificial Hearts
Table 14. South Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 15. United Arab Emirates Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Surgery Type
Table 16. United Arab Emirates Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Type
Table 17. United Arab Emirates Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Artificial Hearts
Table 18. United Arab Emirates Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 19. Rest of Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Surgery Type
Table 20. Rest of Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Type
Table 21. Rest of Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Artificial Hearts
Table 22. Rest of Middle East and Africa Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 23. Recent Inorganic Growth Strategies in the Heart Transplant Market
Table 24. Recent Organic Growth Strategies in the Heart Transplant Market
Â
LIST OF FIGURES
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Heart Transplant Market Revenue (US$ Million), 2020 – 2030
Figure 4. Heart Transplant Market Share (%) – Surgery Type, 2022 and 2030
Figure 5. Orthotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Heterotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Heart Transplant Market Share (%) – Type, 2022 and 2030
Figure 8. Donor Live Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Artificial Hearts Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Ventricular Assisted Device Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Total Artificial Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Heart Transplant Market Share (%) – End User, 2022 and 2030
Figure 13. Hospitals Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Cardiac Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. Middle East & Africa: Heart Transplant Market, by Key Country – Revenue (2022) (US$ Million)
Figure 17. Middle East and Africa: Heart Transplant Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 18. Saudi Arabia: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 19. South Africa: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 20. United Arab Emirates: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 21. Rest of Middle East and Africa: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 22. Growth Strategies in the Heart Transplant Market
1. Terumo Corp
2. Abbott Laboratories
3. SynCardia Systems LLC
4. LivaNova Plc
You must be logged in to post a review.
Reviews
There are no reviews yet.